Purchase this article with an account.
Michelle Y. Cho, A J. Kanellopoulos; Clinical Evaluation of Phakic Intraocular Lens Implantation for High Myopia. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4048.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the safety, efficacy, and clinical parameters of the AcrySof Cachet phakic intraocular lens (Alcon, Fort Worth, TX) in the visual rehabilitation of high myopia.
25 eyes of 18 consecutive patients with moderate to high myopia were evaluated preoperatively and six months postoperatively following implantation of the AcrySof Cachet phakic intraocular lens. Baseline and outcome measures included age, uncorrected distance visual acuity (UCVA), best-spectacle corrected visual acuity (BSCVA), manifest refraction with cylinder (C), topographic cylinder change (TCc), and endothelial cell count (ECC).
The mean age of the patients undergoing this procedure was 27 years old. The mean differences between the pre- and postoperative clinical parameters were the following: change in UCVA from 20/400 to 20/25; change in BSCVA 20/25 to 20/18; spherical equivalent reduction from 10.2 to 0.5 diopters, change in cylinder from -1.75 to 1-.25 diopters, and mean TCc -0.35. The endothelial cell count remained unchanged (preoperative 2650, postoperative 2550). No complications were encountered in this group.
The AcrySof Cachet phakic intraocular lens appears to be safe and effective in high myopia.
This PDF is available to Subscribers Only